US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals: market research reports

The pharmaceutical industry is a $1 trillion-dollar sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.

  • Biopharmaceuticals (286)
  • Diseases & Conditions (3829)
  • Drug Delivery (293)
  • Therapeutic Area (7293)
  • Vaccines (728)
RSS Feeds

Pharmaceuticals market research reports and industry analysis

< prev 1    3  4  5  6  7  8  9  10  
Greece Pharmaceuticals and Healthcare Report Q2 2014
4/23/2014 | published by: Business Monitor International
... medium- to long term. Furtherdiscussions with country's troika of lenders clearly indicate that more cuts to spending are on the horizon. With the government continuing to target the pharmaceutical and healthcare sector for cost savings, ...  |  read more...
$1,295.00
South Africa Pharmaceuticals and Healthcare Report Q2 2014
4/23/2014 | published by: Business Monitor International
... and poised for high single-digitgrowth over the next decade. This quarter highlighted issues surrounding intellectual property protection,in which the Innovative Pharmaceutical Association SA (IPASA) was implicated in the leakage of draftresponse campaigning against proposed changes ...  |  read more...
$1,295.00
Mental Health & Substance Abuse Services
4/21/2014 | published by: First Research, Inc.
... include CRC Health and The Betty Ford Center (both based in the US), the Centre for Addiction and Mental Health (Canada), and the Crossroads Centre (Antigua). Globally, resources for mental health services vary by region ...  |  read more...
$129.00
Zhejiang Hangzhou Xinfu Pharmaceutical Co.,Ltd. : Ingredients - Company Profile, SWOT & Financial Report
4/20/2014 | published by: Canadean Ltd
... and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, key employees, company locations and subsidiaries as ...  |  read more...
$125.00
Standard Chem. & Pharm. Co., Ltd. : Ingredients - Company Profile, SWOT & Financial Report
4/20/2014 | published by: Canadean Ltd
... depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, key employees, company locations and ...  |  read more...
$125.00
Chattem, Inc.: Consumer Packaged Goods - Company Profile & SWOT Report
4/18/2014 | published by: Canadean Ltd
... its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, recent developments as well as company locations and subsidiaries. Summary This report is a crucial ...  |  read more...
$125.00
GlaxoSmithkline Consumer Healthcare Ltd. : Consumer Packaged Goods - Company Profile, SWOT & Financial Report
4/18/2014 | published by: Canadean Ltd
... depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, key competitors, financial analysis, mergers & acquisitions, ...  |  read more...
$125.00
Chengzhi Co., Ltd : Ingredients - Company Profile, SWOT & Financial Report
4/18/2014 | published by: Canadean Ltd
... company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, recent developments, key employees, company locations and subsidiaries as well as ...  |  read more...
$125.00
Bioactive Ingredients & Product Market by Ingredient (Probiotics, Proteins, Plant Extracts, Minerals, Vitamins, Fibers, Carotenoids), by Product (Functional Foods, & Beverage, Dietary Supplements, Animal Nutrition, Personal Care) - Global Trends & Forecas
4/17/2014 | published by: MarketsandMarkets
... The market for bioactive ingredients is projected to experience a growth rate of 7.2% by 2018 to touch $33.6 billion. This estimation is attributed to the widening bioactive industry, which is a result of increased ...  |  read more...
$4,650.00
Vendor Assessment: 2013 Top 10 Life Science Software Vendors
4/17/2014 | published by: IDC
... annually since 2010, the 2013 IDC Health Insights top 10 life science software vendors list includes expanded insights into life science vendor rankings within the life science industry subsegments, research, development, manufacturing and supply chain, ...  |  read more...
$4,500.00
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
... wholesale andretail prices of imported drugs, which will limit trade. However, the government's focus on imports of lowcostdrugs directly from the governments of Bangladesh and Thailand, using the state pharmaceuticalcorporation, will limit dependency on Indian ...  |  read more...
$1,295.00
Venezuela Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
... and effective communication with the Venezuelan government are vital for the survivalof domestic pharmaceutical companies. As the Venezuelan government tries to increase access tomedicines, more co-ordination with drug producers to address these issues will become ...  |  read more...
$1,295.00
Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
... present more commercialbenefits to companies dealing with inexpensive generic drugs and over-the-counter products thaninnovative pharmaceuticals. Headline Expenditure Projections Pharmaceuticals: KHR828.7bn (US$210mn) in 2013 to KHR921.9bn (US$230mn) in 2014; +11.2% inlocal currency terms and +11.8% in ...  |  read more...
$1,295.00
Bahrain Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
... potential advancement towardsthe implementation of a unified Gulf Cooperation Council pricing system. Although less optimistic thanbefore, our medium- and long-term outlooks for the Bahrain pharmaceutical market remain bullish. Medicines uptake will be supported by robust ...  |  read more...
$1,295.00
Denmark Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
... population. This demand could provide opportunities for private healthcare providers to expand asthe government continues its restructuring and cost containment measures across the public healthcaresector. Headline Expenditure Projections Pharmaceuticals: DKK20.20bn (US$3.58bn) in 2013 to DKK20.02bn ...  |  read more...
$1,295.00
Iraq Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
... represent and appease thecountry's factions. Given the government's expansionary fiscal policy, spending on education, health andpublic services will be elevated over the coming quarters. In particular, Baghdad will seek to modernisehealthcare provision, in a view ...  |  read more...
$1,295.00
Lithuania Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
... While double-digit annualgrowth rates are firmly in the past, some opportunities continue to exist in light of epidemiological factorsand an ageing population. The upcoming switch to the euro promises to boost purchasing power andstabilise the ...  |  read more...
$1,295.00
Hepatitis Drugs Markets in China
4/16/2014 | published by: Asia Market Information & Development Company
... new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and ...  |  read more...
$4,000.00
Czech Republic Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
... and access to healthcare servicesis expected to continue its steady growth trajectory, putting pressure on the state and insurers to raisepremiums or redistribute funding. Following the release of pharmaceutical sales data by the SUKL, wehave ...  |  read more...
$1,295.00
Sector Report Specialty Pharmaceuticals Industry
4/16/2014 | published by: Bourne Capital Partners, L.L.C.
... continue to increase. Industry growth is anticipated to continue as is merger and acquisition volume. Bourne Partners Specialty Pharmaceuticals Industry Sector Report offers unique insight into industry trends and trading and transaction comparables from across ...  |  read more...
$495.00
Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014
4/15/2014 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Recurrent Glioblastoma Multiforme (GBM). It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
$2,500.00
Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014
4/15/2014 | published by: GlobalData
... trial scenario. This report provides elemental information and data relating to the clinical trials on Refractory Acute Myeloid Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site ...  |  read more...
$2,500.00
Refractory Leukemia Global Clinical Trials Review, H1, 2014
4/15/2014 | published by: GlobalData
... information and data relating to the clinical trials on Refractory Leukemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
$2,500.00
Refractory Multiple Myeloma Global Clinical Trials Review, H1, 2014
4/15/2014 | published by: GlobalData
... report provides elemental information and data relating to the clinical trials on Refractory Multiple Myeloma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...  |  read more...
$2,500.00
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H1, 2014
4/15/2014 | published by: GlobalData
... Tumor (Neurofibrosarcoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peripheral Nerve Sheath Tumor (Neurofibrosarcoma). It includes an overview of the trial numbers and their recruitment status ...  |  read more...
$2,500.00
< prev 1    3  4  5  6  7  8  9  10  
 
Our Clients